Search Results - "Marquart, J. A."

Lipopolysaccharide Is Transferred from High-Density to Low-Density Lipoproteins by Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein by Levels, J. H. M, Marquart, J. A, Abraham, P. R, van den Ende, A. E, Molhuizen, H. O. F, van Deventer, S. J. H, Meijers, J. C. M

“…Lipopolysaccharide (LPS), the major outer membrane component of gram-negative bacteria, is a potent endotoxin that triggers cytokine-mediated systemic…”
Get full text

Preferential Protection of Borrelia burgdorferi Sensu Stricto by a Salp15 Homologue in Ixodes ricinus Saliva by Hovius, J. W., Schuijt, T. J., de Groot, K. A., Roelofs, J. J. T. H., Oei, G. A., Marquart, J. A., de Beer, R., van't Veer, C., van der Poll, T., Ramamoorthi, N., Fikrig, E., van Dam, A. P.

“…Background. Ixodes ticks are the main vectors for Borrelia burgdorferi sensu lato. In the United States, B. burgdorferi is the sole causative agent of Lyme…”
Get full text

Selective modulation of thrombin‐activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin‐thrombomodulin complex using TAFI‐derived peptides by Plug, T., Marquart, J. A., Marx, P. F., Meijers, J. C. M.

“…Summary Background Thrombin‐activatable fibrinolysis inhibitor (TAFI) is a risk factor for coronary heart disease. TAFI is proteolytically activated by…”
Get full text

Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes by VAN OS, G. M. A., MEIJERS, J. C. M., AGAR, Ç., SERON, M. V., MARQUART, J. A., ÅKESSON, P., URBANUS, R. T., DERKSEN, R. H. W. M., HERWALD, H., MÖRGELIN, M., DE GROOT, P. G.

“…Background: The antiphospholipid syndrome (APS) is characterized by the persistent presence of anti‐β2‐glycoprotein I (β2‐GPI) autoantibodies. β2‐GPI can exist…”
Get full text

Protein C inhibitor may modulate human sperm-oocyte interactions by ELISEN, M. G. L. M, VAN KOOIJ, R. J, NOLTE, M. A, MARQUART, J. A, LOCK, T. M. T. W. T, BOUMA, B. N, MEIJERS, J. C. M

“…Protein C inhibitor (PCI) is a heparin-binding plasma serine protease inhibitor that was originally identified as an inhibitor of activated protein C. PCI has…”
Get full text

Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains by van der Plas, R M, Gomes, L, Marquart, J A, Vink, T, Meijers, J C, de Groot, P G, Sixma, J J, Huizinga, E G

“…Binding of von Willebrand Factor (vWF) to sites of vascular injury is the first step of hemostasis. Collagen types I and III are important binding sites for…”
Get more information

Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model by van Montfoort, M L, Knaup, V L, Marquart, J A, Bakhtiari, K, Castellino, F J, Hack, C E, Meijers, J C M

“…Coagulation factor XI (FXI) is a promising target for anticoagulation, because of its major role in thrombosis and relatively minor role in haemostasis. This…”
Get more information

Induction of anti- beta 2-glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes by VAN OS, GMA, MEIJERS, JCM, Agar, C, Seron, M V, Marquart, Ja, AaKESSON, P, Urbanus, R T, DERKSEN, RHWM, Herwald, H, MOeRGELIN, M, DE GROOT, PG

“…Background:The antiphospholipid syndrome (APS) is characterized by the persistent presence of anti- beta 2-glycoprotein I ( beta 2-GPI) autoantibodies. beta…”
Get full text

Evolutionary conservation of the lipopolysaccharide binding site of β₂-glycoprotein I by Ağar, Çetin, de Groot, Philip G, Marquart, J Arnoud, Meijers, Joost C M

“…β₂-Glycoprotein I (β₂GPI) is a highly abundant plasma protein and the major antigen for autoantibodies in the antiphospholipid syndrome. Recently, we have…”
Get more information

Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B by Valls Serón, Mercedes, Plug, Tom, Marquart, J Arnoud, Marx, Pauline F, Herwald, Heiko, de Groot, Philip G, Meijers, Joost C M

“…Streptococcus pyogenes is the causative agent in a wide range of diseases in humans. Thrombin-activatable fibrinolysis inhibitor (TAFI) binds to collagen-like…”
Get more information

Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes by van Os, G M A, Meijers, J C M, Ağar, C, Valls Serón, M, Marquart, J A, Åkesson, Per, Urbanus, R T, Derksen, R H W M, Herwald, Heiko, Mörgelin, Matthias, de Groot, P G

“…Background: The antiphospholipid syndrome (APS) is characterized by the persistent presence of auto-antibodies against β(2) -Glycoprotein I (β(2) -GPI). β(2)…”
Get full text

Preferential Protection of Borrelia burgdorferi Sensu Stricto by a Salp 15 Homologue in Ixodes ricinus Saliva by Hovius, J. W., Schuijt, T. J., de Groot, K. A., Roelofs, J. J. T. H., Oei, G. A., Marquart, J. A., de Beer, R., van't Veer, C., van der Poll, T., Ramamoorthi, N., Fikrig, E., van Dam, A. P.

“…Background. Ixodes ticks are the main vectors for Borrelia burgdorferi sensu lato. In the United States, B. burgdorferi is the sole causative agent of Lyme…”
Get full text

The influence of applicants' gender on medical school interviews by Marquart, J A, Franco, K N, Carroll, B T

“…Although medicine has been traditionally a man's profession, a full third of medical students are now women, and in some schools nearly a half. Only a few…”
Get more information

Preferential Protection of Borrelia burgdorferi Sensu Stricto by a Salpl5 Homologue in Ixodes ricinus Saliva by HOVIUS, J. W, SCHUIJT, T. J, FIKRIG, E, VAN DAM, A. P, DE GROOT, K. A, ROELOFS, J. J. T. H, OEI, G. A, MARQUART, J. A, DE BEER, R, VAN 'T VEER, C, VAN DER POLL, T, RAMAMOORTHI, N

Get full text

Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B by Seron, Valls M., Marx, P. F., Marquart, J. A., Herwald, Heiko, de Groot, P. G., Meijers, J. C. M.

Get full text

Generation and Characterization of a Highly Stable Form of Activated Thrombin-activable Fibrinolysis Inhibitor by Marx, Pauline F., Havik, Stefan R., Marquart, J. Arnoud, Bouma, Bonno N., Meijers, Joost C.M.

“…Activated thrombin-activable fibrinolysis inhibitor (TAFIa) is a carboxypeptidase B that can down-regulate fibrinolysis. TAFIa is a labile enzyme that can be…”
Get full text

Protein C inhibitor (plasminogen activator inhibitor‐3) and the risk of venous thrombosis by Meijers, Joost C. M., Marquart, J. Arnoud, Bertina, Rogier M., Bouma, Bonno N., Rosendaal, Frits R.

“…Protein C inhibitor (PCI), also known as plasminogen activator inhibitor‐3, is a serine proteinase inhibitor that can inhibit enzymes in blood coagulation,…”
Get full text